Advertisement
Strategies & Technologies Driving Drug Discovery to Market
Subscribe to Drug Discovery & Development All
View Sample

FREE Email Newsletter

DDD Update

Daily news and top headlines for drug research professionals

FDA Approves Actavis', Medicines360's Long-Term Contraception

March 2, 2015 10:06 am | News | Comments

Actavis plc, a leading global specialty pharmaceutical company, and Medicines360, a nonprofit women's health pharmaceutical company, announced the approval of Liletta (levonorgestrel-releasing intrauterine system) by the U.S. Food and Drug Administration (FDA) for use by women to prevent pregnancy for up to three years. Read more...

TOPICS:

Mylan Completes Acquisition Of Abbott's Non-U.S. Developed Markets

March 2, 2015 9:58 am | News | Comments

​Mylan N.V. and Mylan Inc. announced the successful completion of the acquisition of Abbott Laboratories' (NYSE: ABT) non-U.S. developed markets specialty and branded generics business. Read more..

TOPICS:

First Treatment Approved in Canada for Adults With ADPKD

March 2, 2015 9:52 am | News | Comments

Otsuka Pharmaceutical Co., Ltd. and its affiliate Otsuka Canada Pharmaceutical Inc. announce that Health Canada has approved JINARC (tolvaptan) as the first pharmaceutical agent for the treatment of autosomal dominant polycystic kidney disease (ADPKD). Read more...

TOPICS:
Advertisement

Sierra Leone's Vice President In Quarantine for Ebola

March 2, 2015 9:36 am | by Clarence Roy-Macaulay, Associated Press | News | Comments

Sierra Leone's vice president has put himself in quarantine following the death from Ebola of one of his security guards. Read more...                                   

TOPICS:

Lyric Pharmaceuticals: $20.4M Series A Funding Round

February 27, 2015 1:41 pm | News | Comments

Lyric Pharmaceuticals Inc. today announced the initial closing of a Series A financing round totaling $20.4 million. Read more...                                     

TOPICS:

Former Sanofi CEO Joins Puretech’s Board of Directors

February 27, 2015 1:29 pm | News | Comments

PureTech, a science and technology R&D company focused  on identifying, inventing and commercializing disruptive products and technologies in the healthcare sector, announced today the appointment of Christopher Viehbacher, former CEO and Member of the Board of Directors of Sanofi, to its Board of Directors.  Read more...

TOPICS:

TSRI Team Shows How Rare Antibody Targets Ebola, Marburg Viruses

February 27, 2015 1:20 pm | by Scripps Research Institute | News | Comments

Marburg virus is Ebola’s deadly cousin. The virus is up to 90 percent lethal—and doctors are desperate for tools to fight it. Read more...

TOPICS:

Making Proactive Asset Management Work for Business

February 27, 2015 1:02 pm | by Ben Potenza, VP Marketing, EquipNet | Articles | Comments

Millions are spent every year on the laboratory equipment and instrumentation that is essential for the daily work of research and analysis in the pharmaceutical, biotechnology and chemical sectors. Read more...                 

TOPICS:
Advertisement

Panel: Use New Meningitis Vaccines Only For Outbreaks

February 27, 2015 12:58 pm | by Mike Stobbe, AP Medical Writer - Associated Press | News | Comments

A federal panel on Thursday recommended that two new meningitis vaccines only be used for rare outbreaks, resisting tearful pleas to give it routinely to teens and college students. Read more...

TOPICS:

Heat Blamed for Spray Vaccine's Failure Against Swine Flu

February 27, 2015 12:53 pm | by Mike Stobbe, AP Medical Writer - Associated Press | News | Comments

The makers of the nasal spray version of the flu vaccine say now they know why it has failed to protect young U.S. children against swine flu - fragile doses got too warm. Read more...

TOPICS:

Takeda's Treatment for Acid-Related Diseases is Now Available in Japan

February 27, 2015 9:10 am | News | Comments

This medicine treats acid-related diseases with a novel mechanism of action called potassium-competitive acid blockers. Read more...                    

TOPICS:

Novartis's Lung Cancer Drug Recommended for EU Approval

February 27, 2015 9:03 am | News | Comments

The medication is meant for patients with ALK+ NSCLC previously treated with crizotinib. Read more...                          

TOPICS:

Pancreatic Cancer Subtypes Could Guide Future Treatments

February 27, 2015 8:42 am | by University of Queensland | News | Comments

Scientists have completed the most comprehensive analysis yet of pancreatic cancer, in a study that could improve future treatments. Read more...                   

TOPICS:

Synthetic Biology Breakthrough Leads to Cheaper Statin Production

February 27, 2015 8:33 am | by University of Manchester | News | Comments

Researchers have devised a single-step fermentative method for the industrial production of the active drug pravastatin. Read more...                     

TOPICS:

Ebola Doctor: Media, Politicians Fueled the Public's Fear

February 27, 2015 8:29 am | by Tom Mcelroy, Associated Press | News | Comments

A doctor who contracted the deadly Ebola virus and rode the subway system and dined out before he developed symptoms said the media and politicians could have done a better job by educating people on the science of it. Read more...     

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading